AAAAAA
Results: 1-25/85
Authors:
PIENEMAN WC
FAY P
BRIET E
REITSMA PH
BERTINA RM
Citation: Wc. Pieneman et al., PARTIAL RECONSTITUTION OF FACTOR-VIII ACTIVITY FROM A MILD CRM(-A PATIENT BY REPLACEMENT OF THE DEFECTIVE A2 DOMAIN() HEMOPHILIA), Thrombosis and haemostasis, 79(5), 1998, pp. 943-948
Authors:
TRIEMSTRA AHM
VANDERPLOEG HM
SMIT C
BRIET E
ADER HJ
ROSENDAAL FR
Citation: Ahm. Triemstra et al., WELL-BEING OF HEMOPHILIA PATIENTS - A MODEL FOR DIRECT AND INDIRECT EFFECTS OF MEDICAL PARAMETERS ON THE PHYSICAL AND PSYCHOSOCIAL FUNCTIONING, Social science & medicine (1982), 47(5), 1998, pp. 581-593
Authors:
ROSENDAAL FR
WALKER ID
PRESTON FE
BRIET E
Citation: Fr. Rosendaal et al., EUROPEAN PROSPECTIVE COHORT ON THROMBOPHILIA (EPCOT) - AN UPDATE, Thrombosis and haemostasis, 1997, pp. 2350-2350
Authors:
VANDERMEER FJM
BRIET E
VANDENBROUCKE JP
SRAMEK DI
VERSLUIJS HPM
ROSENDAAL FR
Citation: Fjm. Vandermeer et al., PATIENT COMPLIANCE IN ORAL ANTICOAGULANT-THERAPY (OAT), Thrombosis and haemostasis, 1997, pp. 2384-2384
Authors:
VANDERMEER FJM
KOSTER T
VANDENBROUCKE JP
BRIET E
ROSENDAAL FR
Citation: Fjm. Vandermeer et al., THE LEIDEN THROMBOPHILIA STUDY (LETS), Thrombosis and haemostasis, 78(1), 1997, pp. 631-635
Authors:
VANDERMEER FJM
BRIET E
VANDENBROUCKE JP
SRAMEK DI
VERSLUIJS MHPM
ROSENDAAL FR
Citation: Fjm. Vandermeer et al., THE ROLE OF COMPLIANCE AS A CAUSE OF INSTABILITY IN ORAL ANTICOAGULANT-THERAPY, British Journal of Haematology, 98(4), 1997, pp. 893-900
Authors:
CANNEGIETER SC
ROSENDAAL FR
BOLLEN ELEM
BRIET E
Citation: Sc. Cannegieter et al., HIGH-INTENSITY OF ORAL ANTICOAGULANT-THERAPY IN PATIENTS WITH CEREBRAL-HEMORRHAGE - CAUSE OR CONSEQUENCE OF THE BLEEDING, British Journal of Haematology, 96(3), 1997, pp. 497-499
Authors:
ALLERSMA DP
SMID WM
BRIET E
Citation: Dp. Allersma et al., ABNORMAL IMMUNE PARAMETERS IN HIV-SERONEGATIVE HEMOPHILIC PATIENTS, Haemophilia, 2(2), 1996, pp. 65-72
Authors:
AZAR AJ
CANNEGIETER SC
DECKERS JW
BRIET E
VANBERGEN PFMM
JONKER JJC
ROSENDAAL FR
Citation: Aj. Azar et al., OPTIMAL INTENSITY OF ORAL ANTICOAGULANT-THERAPY AFTER MYOCARDIAL-INFARCTION, Journal of the American College of Cardiology, 27(6), 1996, pp. 1349-1355
Authors:
VANDERMEER FJM
ROSENDAAL FR
VANDENBROUCKE JP
BRIET E
Citation: Fjm. Vandermeer et al., ASSESSMENT OF A BLEEDING RISK INDEX IN 2 COHORTS OF PATIENTS TREATED WITH ORAL ANTICOAGULANTS, Thrombosis and haemostasis, 76(1), 1996, pp. 12-16
Authors:
ALLERSMA DP
SMID WM
VANDERDOES JA
VANDERMEER J
BRIET E
Citation: Dp. Allersma et al., EFFECTS OF CHRONIC FACTOR-VIII SUBSTITUTION ON IMMUNE PARAMETERS IN HIV SERONEGATIVE HEMOPHILIACS - A COMPARISON BETWEEN CRYOPRECIPITATE AND FACTOR-VIII CONCENTRATE, Thrombosis and haemostasis, 75(2), 1996, pp. 261-266
Authors:
KRULDER JWM
STREBUS AF
MEINDERS AE
BRIET E
Citation: Jwm. Krulder et al., ANTICOAGULANT EFFECT OF UNFRACTIONATED HEPARIN IN ANTITHROMBIN-DEPLETED PLASMA IN-VITRO, Haemostasis, 26(2), 1996, pp. 85-89
Authors:
KRULDER JWM
VANDERMEER FJM
BRIET E
MEINDERS AE
Citation: Jwm. Krulder et al., MONITORING HEPARIN TREATMENT WITH THE APTT - THE EFFECT OF METHODOLOGICAL CHANGES ON THE APTT, Netherlands journal of medicine, 49(1), 1996, pp. 13-18
Authors:
FALLAUX FJ
HOEBEN RC
CRAMER SJ
VANDENWOLLENBERG DJM
BRIET E
VANORMONDT H
VANDEREB AJ
Citation: Fj. Fallaux et al., THE HUMAN CLOTTING FACTOR-VIII CDNA CONTAINS AN AUTONOMOUSLY REPLICATING SEQUENCE CONSENSUS-LIKE AND MATRIX ATTACHMENT REGION-LIKE SEQUENCETHAT BINDS A NUCLEAR FACTOR, REPRESSES HETEROLOGOUS GENE-EXPRESSION, AND MEDIATES THE TRANSCRIPTIONAL EFFECTS OF SODIUM-BUTYRATE, Molecular and cellular biology, 16(8), 1996, pp. 4264-4272
Authors:
PRESTON FE
ROSENDAAL FR
WALKER ID
BRIET E
BERNTORP E
CONARD J
FONTCUBERTA J
MAKRIS M
MARIANI G
NOTEBOOM W
PABINGER I
LEGNANI C
SCHARRER I
SCHULMAN S
VANDERMEER FJM
Citation: Fe. Preston et al., INCREASED FETAL LOSS IN WOMEN WITH HERITABLE THROMBOPHILIA, Lancet, 348(9032), 1996, pp. 913-916
Authors:
NOVOTNY VMJ
HUIZINGA TWJ
VANDOORN R
BRIET E
BRAND A
Citation: Vmj. Novotny et al., HLA CLASS I-ELUTED PLATELETS AS AN ALTERNATIVE TO HLA-MATCHED PLATELETS, Transfusion, 36(5), 1996, pp. 438-444
Authors:
DENHEIJER M
KOSTER T
BLOM HJ
BOS GMJ
BRIET E
REITSMA PH
VANDENBROUCKE JP
ROSENDAAL FR
Citation: M. Denheijer et al., HYPERHOMOCYSTEINEMIA AS A RISK FACTOR FOR DEEP-VEIN THROMBOSIS, The New England journal of medicine, 334(12), 1996, pp. 759-762
Authors:
PRESTON FE
WALKER ID
ROSENDAAL FR
BRIET E
Citation: Fe. Preston et al., INCREASED FETAL LOSS IN WOMEN WITH THROMBOPHILIA, British Journal of Haematology, 93, 1996, pp. 19-19
Authors:
EIKENBOOM JCJ
MATSUSHITA T
REITSMA PH
TULEY EA
CASTAMAN G
BRIET E
SADLER JE
Citation: Jcj. Eikenboom et al., DOMINANT TYPE-1 VON-WILLEBRAND DISEASE CAUSED BY MUTATED CYSTEINE RESIDUES IN THE D3 DOMAIN OF VON-WILLEBRAND-FACTOR, Blood, 88(7), 1996, pp. 2433-2441
Authors:
PRESTON FE
WALKER ID
ROSENDAAL FR
BRIET E
Citation: Fe. Preston et al., INCREASED FETAL LOSS IN HERITABLE THROMBOPHILIA, Blood, 88(10), 1996, pp. 1125-1125
Authors:
TRIEMSTRA AHM
SMIT C
VANDERPLOEG HM
BRIET E
ROSENDAAL FR
Citation: Ahm. Triemstra et al., 2 DECADES OF HEMOPHILIA TREATMENT IN THE NETHERLANDS, 1972-92, Haemophilia, 1(3), 1995, pp. 165-171
Authors:
EIKENBOOM JCJ
REITSMA PH
BRIET E
Citation: Jcj. Eikenboom et al., THE INHERITANCE AND MOLECULAR-GENETICS OF VON WILLEBRANDS DISEASE, Haemophilia, 1(2), 1995, pp. 77-90
Authors:
ALLAART CF
ROSENDAAL FR
NOTEBOOM WMP
VANDENBROUCKE JP
BRIET E
Citation: Cf. Allaart et al., SURVIVAL IN FAMILIES WITH HEREDITARY PROTEIN-C DEFICIENCY, 1820 TO 1993, BMJ. British medical journal, 311(7010), 1995, pp. 910-913
Authors:
VELTMAN GAM
BRAND A
LEEKSMA OC
TENBOSCH GJA
VANKRIEKEN JHJM
BRIET E
Citation: Gam. Veltman et al., THE ROLE OF SPLENECTOMY IN THE TREATMENT OF RELAPSING THROMBOTIC THROMBOCYTOPENIC PURPURA, Annals of hematology, 70(5), 1995, pp. 231-236
Authors:
FALLAUX FJ
HOEBEN RC
BRIET E
Citation: Fj. Fallaux et al., STATE AND PROSPECTS OF GENE-THERAPY FOR THE HEMOPHILIAS, Thrombosis and haemostasis, 74(1), 1995, pp. 266-273